Story Brooke 4
4 · Sigilon Therapeutics, Inc. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
Story Brooke
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-14+17,777→ 17,777 totalExercise: $11.19Exp: 2031-06-13→ Common Stock (17,777 underlying)
Footnotes (1)
- [F1]The option vest as to one-third of the shares on each of June 14, 2022, June 14, 2023 and June 14, 2024.